Cervical Cancer Screening and Incidence by Age: Unmet Needs Near and After the Stopping Age for Screening

White, Mary C.; Shoemaker, Meredith L.; Benard, Vicki B.

doi:10.1016/j.amepre.2017.02.024

Cited by 53 publications

(57 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Several studies have found lower participation in screening programs among older groups of women than in younger patients . Some authors have reported that most 65‐year‐old patients do not fulfill all criteria for leaving cervical screening .…”

Section: Discussionmentioning

confidence: 99%

Distribution of cervical lesions in young and older women

Arco

Ayala

García

et al. 2019

Diagnostic Cytopathology

View full text Add to dashboard Cite

Introduction Age range for cervical screening varies widely between countries. In addition, sexual behavior has changed, life expectancy is increasing, and new insights have been gained into the pathogenesis of HPV infection. Our aim is to evaluate the distribution of cervical lesions in young and older patients. Methods Review of all cervical smears diagnosed in a public institution (2010‐2017) and a private institution (2016‐2017) in Madrid, Spain. We have included all women aged younger than 30 and older than 65 years with atypical smears (n = 1573). Results Women younger than 30 years were diagnosed with ASCUS, ASC‐H, LSIL, and HSIL in 47%, 5.3%, 45.17%, and 2.6% of atypical cases, respectively. Women older than 65 years were diagnosed with ASCUS, ASC‐H, LSIL, HSIL, and SCC in 38%, 12.39%, 16.8%, 13.27%, and 19.5% of atypical cases, respectively. Medical records of patients from the public institution were reviewed. Of note, 76.3% of young women showed negative smears at follow‐up and 14.1% showed high‐grade dysplasia (HGD). Mean ages for low‐grade and HGD were 24.7 and 25.7 years, respectively. HGD was found in 37.9% of women with histological examination (33.5%). As for older patients, 25% of them had no Pap smears performed before age 65, and in 60% of the previously screened women, the screening program had not been used adequately. Mean age of first smear was 69.5 years. Carcinoma was subsequently detected in 20.7% of patients. Conclusions Current guidelines seem to be adequately preventing carcinoma in young women. However, screening adherence should be encouraged to detect important lesions in both age groups, especially among older women.

show abstract

Section: Discussionmentioning

confidence: 99%

Distribution of cervical lesions in young and older women

Arco

Ayala

García

et al. 2019

Diagnostic Cytopathology

View full text Add to dashboard Cite

show abstract

“…According to 2015 data from the NHIS, 86% of NH black women and 85% of NH white women were up to date on cervical cancer screening (Table ). A recent study, however, found substantially lower screening prevalence among older women; for example, 22% to 24% of NH black women aged 61 to 70 years had not had a Papanicolaou test within 5 years, compared with 7% among those aged 41 to 45 years …”

Section: Selected Findingsmentioning

confidence: 92%

“…An estimated 2,250 new cases of invasive cervical cancer and 770 deaths are expected to occur among black women in 2019. The incidence rate of cervical cancer is 30% higher in NH black women than in NH white women (Table ) with the largest disparity among older women . The black‐white disparity is even greater when incidence rates are adjusted for hysterectomy prevalence, which is higher in black women .…”

Section: Selected Findingsmentioning

confidence: 99%

See 1 more Smart Citation

Cancer statistics for African Americans, 2019

DeSantis

Miller

Sauer

et al. 2019

CA A Cancer J Clinicians

611

555

View full text Add to dashboard Cite

In the United States, African American/black individuals bear a disproportionate share of the cancer burden, having the highest death rate and the lowest survival rate of any racial or ethnic group for most cancers. To monitor progress in reducing these inequalities, every 3 years the American Cancer Society provides the estimated number of new cancer cases and deaths for blacks in the United States and the most recent data on cancer incidence, mortality, survival, screening, and risk factors using data from the National Cancer Institute, the North American Association of Central Cancer Registries, and the National Center for Health Statistics. In 2019, approximately 202,260 new cases of cancer and 73,030 cancer deaths are expected to occur among blacks in the United States. During 2006 through 2015, the overall cancer incidence rate decreased faster in black men than in white men (2.4% vs 1.7% per year), largely due to the more rapid decline in lung cancer. In contrast, the overall cancer incidence rate was stable in black women (compared with a slight increase in white women), reflecting increasing rates for cancers of the breast, uterine corpus, and pancreas juxtaposed with declining trends for cancers of the lung and colorectum. Overall cancer death rates declined faster in blacks than whites among both males (2.6% vs 1.6% per year) and females (1.5% vs 1.3% per year), largely driven by greater declines for cancers of the lung, colorectum, and prostate. Consequently, the excess risk of overall cancer death in blacks compared with whites dropped from 47% in 1990 to 19% in 2016 in men and from 19% in 1990 to 13% in 2016 in women. Moreover, the black‐white cancer disparity has been nearly eliminated in men <50 years and women ≥70 years. Twenty‐five years of continuous declines in the cancer death rate among black individuals translates to more than 462,000 fewer cancer deaths. Continued progress in reducing disparities will require expanding access to high‐quality prevention, early detection, and treatment for all Americans.

show abstract

“…Cancer registries have been used to provide compelling data documenting variations in cancer incidence and cancer mortality within and among different populations . Combined data from the NPCR and SEER registries have provided sufficient numbers of incident cases to examine rare cancers, specific histologic types, cancers at specific ages, and regional variations . In addition to contributing critical knowledge regarding patterns in cancer occurrence and a resource for cancer researchers, cancer surveillance data provide essential data with which to guide cancer prevention and control activities at the national, state, and local levels.…”

Section: Discussionmentioning

confidence: 99%

The history and use of cancer registry data by public health cancer control programs in the United States

White

Babcock

Hayes

et al. 2017

Cancer

Self Cite

105

View full text Add to dashboard Cite

Because cancer registry data provide a census of cancer cases, registry data can be used to: 1) define and monitor cancer incidence at the local, state, and national levels; 2) investigate patterns of cancer treatment; and 3) evaluate the effectiveness of public health efforts to prevent cancer cases and improve cancer survival. The purpose of this article is to provide a broad overview of the history of cancer surveillance programs in the United States, and illustrate the expanding ways in which cancer surveillance data are being made available and contributing to cancer control programs. The article describes the building of the cancer registry infrastructure and the successful coordination of efforts among the 2 federal agencies that support cancer registry programs, the Centers for Disease Control and Prevention and the National Cancer Institute, and the North American Association of Central Cancer Registries. The major US cancer control programs also are described, including the National Comprehensive Cancer Control Program, the National Breast and Cervical Cancer Early Detection Program, and the Colorectal Cancer Control Program. This overview illustrates how cancer registry data can inform public health actions to reduce disparities in cancer outcomes and may be instructional for a variety of cancer control professionals in the United States and in other countries.

show abstract

Cervical Cancer Screening and Incidence by Age: Unmet Needs Near and After the Stopping Age for Screening

Cited by 53 publications

References 13 publications

Distribution of cervical lesions in young and older women

Distribution of cervical lesions in young and older women

Cancer statistics for African Americans, 2019

The history and use of cancer registry data by public health cancer control programs in the United States

Contact Info

Product

Resources

About